Balaxi Pharmaceuticals consolidated net profit rises 52.03% in the March 2022 quarter

24 May 2022 , 02:24 PM

Net profit of Balaxi Pharmaceuticals rose 52.03% to Rs 12.71 crore in the quarter ended March 2022 as against Rs 8.36 crore during the previous quarter ended March 2021. Sales rose 68.27% to Rs 89.10 crore in the quarter ended March 2022 as against Rs 52.95 crore during the previous quarter ended March 2021. For the full year,net profit rose 24.96% to Rs 47.66 crore in the year ended March 2022 as against Rs 38.14 crore during the previous year ended March 2021. Sales rose 20.78% to Rs 279.39 crore in the year ended March 2022 as against Rs 231.33 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	89.10	52.95	68	279.39	231.33	21
OPM %	12.59	19.47	–	17.97	18.33	–
PBDT	15.19	10.03	51	55.03	44.63	23
PBT	15.02	9.97	51	54.52	44.33	23
NP	12.71	8.36	52	47.66	38.14	25

Powered by Capital Market – Live News